Efficient new constructs against triple negative breast cancer cells: synthesis and preliminary biological study of ferrocifen-SAHA hybrids and related species. (Q39096632)

From Wikidata

Jump to navigation Jump to search

scientific article published on November 2013

Language	Label	Description	Also known as
English	Efficient new constructs against triple negative breast cancer cells: synthesis and preliminary biological study of ferrocifen-SAHA hybrids and related species.	scientific article published on November 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030275%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Efficient new constructs against triple negative breast cancer cells: synthesis and preliminary biological study of ferrocifen-SAHA hybrids and related species (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030275%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Marion Lapierre

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030275%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Vincent Cavailles

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030275%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030275%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030275%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

6

object named as

Siden Top

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030275%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

José de Jesús Cázares-Marinero

1

object named as

José de Jesús Cázares Marinero

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030275%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

Rénette Saint-Fort

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030275%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

language of work or name

0 references

publication date

1 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030275%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Dalton Transactions

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030275%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

42

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030275%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

43

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030275%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

15489-15501

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030275%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Organometallic compounds: an opportunity for chemical biology?

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Inorganic chemical biology: from small metal complexes in biological systems to metalloproteins

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Targeting proteins with metal complexes

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Organometallic anticancer compounds

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

The first organometallic selective estrogen receptor modulators (SERMs) and their relevance to breast cancer

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR.

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Synthesis and structure-activity relationships of ferrocenyl tamoxifen derivatives with modified side chains

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Metal complex SERMs (selective oestrogen receptor modulators). The influence of different metal units on breast cancer cell antiproliferative effects

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

A [3]ferrocenophane polyphenol showing a remarkable antiproliferative activity on breast and prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Modification of the estrogenic properties of diphenols by the incorporation of ferrocene. Generation of antiproliferative effects in vitro

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

A series of unconjugated ferrocenyl phenols: prospects as anticancer agents

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Role of aromatic substituents on the antiproliferative effects of diphenyl ferrocenyl butene compounds

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Electrochemical parameters and techniques in drug development, with an emphasis on quinones and related compounds

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Aminoferrocene-based prodrugs activated by reactive oxygen species.

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

DNA methylation and gene silencing in cancer

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Epigenetics: an expanding new piece of the stroke puzzle

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Histone deacetylase inhibitors: from bench to clinic

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Radiosensitizing potential of epigenetic anticancer drugs.

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Anticancer activities of histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Discovery of a tetrahydroisoquinoline-based hydroxamic acid derivative (ZYJ-34c) as histone deacetylase inhibitor with potent oral antitumor activities

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Potential anti-cancer activity of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a histone deacetylase inhibitor, against breast cancer both in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Activity of suberoylanilide hydroxamic Acid against human breast cancer cells with amplification of her-2.

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Histone Deacetylase Inhibitors

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Use of the nitrile oxide cycloaddition (NOC) reaction for molecular probe generation: a new class of enzyme selective histone deacetylase inhibitors (HDACIs) showing picomolar activity at HDAC6.

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Incorporation of histone deacetylase inhibition into the structure of a nuclear receptor agonist

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Biological and biophysical properties of the histone deacetylase inhibitor suberoylanilide hydroxamic acid are affected by the presence of short alkyl groups on the phenyl ring.

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activity.

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Synthesis and Biological Evaluation of JAHAs: Ferrocene-Based Histone Deacetylase Inhibitors

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Structural requirements of HDAC inhibitors: SAHA analogs functionalized adjacent to the hydroxamic acid

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Omega-alkoxy analogues of SAHA (vorinostat) as inhibitors of HDAC: a study of chain-length and stereochemical dependence.

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Oxime amides as a novel zinc binding group in histone deacetylase inhibitors: synthesis, biological activity, and computational evaluation.

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Inhibition of histone deacetylase enhances the anti-proliferative action of antiestrogens on breast cancer cells and blocks tamoxifen-induced proliferation of uterine cells

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Vorinostat increases carboplatin and paclitaxel activity in non-small-cell lung cancer cells

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Suberoylanilide hydroxamic acid (SAHA) potentiates paclitaxel-induced apoptosis in ovarian cancer cell lines

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis, which is opposed by the induction of autophagy

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Syntheses and therapeutic potential of hydroxamic acid based siderophores and analogs

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Oestrogen receptor alpha increases p21(WAF1/CIP1) gene expression and the antiproliferative activity of histone deacetylase inhibitors in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

A ferrocenyl derivative of hydroxytamoxifen elicits an estrogen receptor-independent mechanism of action in breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Advances in metal-induced oxidative stress and human disease

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Redox modulation of p53: mechanisms and functional significance

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Redox regulation of p53, redox effectors regulated by p53: a subtle balance

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Synthesis and biological activity of ferrocenyl derivatives of the non-steroidal antiandrogens flutamide and bicalutamide

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Ferrocene-Mediated Proton-Coupled Electron Transfer in a Series of Ferrocifen-Type Breast-Cancer Drug Candidates

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Electrochemical attachment of a conjugated amino–ferrocifen complex onto carbon and metal surfaces

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

The replacement of a phenol group by an aniline or acetanilide group enhances the cytotoxicity of 2-ferrocenyl-1,1-diphenyl-but-l-ene compounds against breast cancer cells

1 reference

https://api.crossref.org/works/10.1039%2FC3DT51917A

21 January 2018

Ferrocifens and Ferrocifenols as New Potential Weapons against Breast Cancer

1 reference

https://opencitations.net/index/coci/api/v1/citations/10.2533/CHIMIA.2007.716

8 July 2023

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39096632&oldid=1931356241"